CCL2 and renal cell carcinoma: Among the mentioned chemokines, the expression of CCL2 has been evaluated in different in vivo studies and cancer patients suffering from prostate, breast, ovarian, gastric, melanoma, and renal cell carcinoma (RCC) [15, 21].